GLP-1 boom expands beyond weight loss
A panel examines the expansion of GLP-1 medications beyond weight loss, exploring new medical uses, potential side effects and what the next wave of these blockbuster drugs could mean for patients on 'Barron's Roundtable.'
AI is the 'ultimate physician extender,' orthopedic surgeon says
Orthopedic surgeon Dr. Andrew D. Pearle discusses how AI is transforming sports medicine, the development of digital twins of joints and how the Hospital for Special Surgery (HSS) is applying AI medical technology to improve patient care.
Democratic Party is in a 'complete free-fall': Lara Trump
'My View with Lara Trump' host Lara Trump discusses New York's 'war' on landlords, Democrat House challengers leading in fundraising against the establishment, President Donald Trump's attendance at the FIFA World Cup final and more.
DSA candidates are so radical they make Kamala Harris seem conservative: Jillian Michaels
'Keeping It Real' podcast host Jillian Michaels discusses the leftward shift in the Democratic Party and comments on a survey saying 10% of couple use GLP-1 drugs before wedding on 'Varney & Co.'
Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access
NFL legend Tom Brady is partnering with eMed to tackle the obesity epidemic by making GLP-1 weight loss medications accessible through employer health benefits.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
Bel North America CEO reveals 'north star' on snacking: 'Democratize better options'
Bel North America CEO Peter McGuinness joins 'Mornings with Maria' to discuss the company's push for healthy snacking options, the big bet on protein snacks and the investment in US production.
Tom Brady opens up about his health amid GLP-1 surge: Water, movement and discipline
Seven-time Super Bowl champ Tom Brady says he wants to break the stigma around willpower as he joins eMed's mission to bring GLP-1 weight-loss support to workers.
The sober shift: Gen Z turning away from alcohol
Soft Bar founder and reality TV star Carl Radke breaks down America’s declining alcohol consumption, his sobriety journey and building a business around the booze-free movement on ‘Maria Bartiromo’s Wall Street.’
NFL legend Drew Brees highlights benefits from 'Stretch Zone' method
Former New Orleans Saint quarterback Drew Brees and Stretch Zone President and CEO Tony Zaccario discuss the growth of Stretch Zone franchises, the benefits of stretching and more on 'The Claman Countdown.'
Novo CEO outlines long-term strategy amid Trump-era drug talks: ‘We’re here to stay’
Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims & Hers and talks with the Trump administration on drug pricing.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight-loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Pfizer CEO addresses growing competition in weight-loss drugs
Pfizer CEO Albert Bourla discusses Pfizer’s Q4 adjusted earnings and the competitive landscape for weight-loss drugs on ‘The Claman Countdown.’
Restaurant owner reveals surprising impact of Ozempic on dining habits
Celebrity chef and restaurant owner Andrew Gruel joins ‘Varney & Co.’ to break down the surprising ways weight loss drugs are hitting restaurant menus, alcohol sales and profit margins across the country.
Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill
Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss medication on FOX Business, saying there's "a lot of excitement."
Wegovy rolls out once-daily weight loss pill; Novo Nordisk exec says not ‘much difference’
Novo Nordisk executive vice president of U.S. operations Dave Moore discusses the drugmaker’s newly launched once-daily oral weight-loss pill on ‘The Claman Countdown.’
Lara Trump defends new nutrition standards for America’s kids
‘My View’ host Lara Trump joins ‘Varney & Co.’ to react to new federal dietary guidelines, warn about processed foods and childhood chronic disease and push back on Democratic attacks against ICE.
Trump to reward states that adopted MAHA policies from rural health care fund
'The Big Money Show' panel weighs in on President Donald Trump's move to reward states that have adopted MAHA policies and discuss the rural health care system.
Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend
Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand for high-protein foods and fitness gear.
San Francisco sues 10 major food manufacturers over ultra-processed foods
City attorney files groundbreaking lawsuit against 10 food manufacturers, claiming ultra-processed products fuel public health crisis with rising disease rates.



















